Internal Medicine, Hematology & Oncology · Springfield, MO
NPI
1477760437
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2055 S Fremont Ave, Suite 1000
Springfield, MO, 65804
Phone (417) 820-8099
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
3,704 services
Medicare patients, 2024
471
Average age 74
Drug cost, 2024
$9.2M
2,765 prescriptions
Company payments, 2025
$756
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica N Snider was code 99214 (office e&m - established), 877 times for 375 patients. In total Jessica N Snider billed 3,704 services in 31 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 877 | 375 | $68.12 | $60K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 833 | 354 | $12.09 | $10K |
| 36415 Venipuncture Blood Collection | Office | 510 | 244 | $8.63 | $4,403 |
| 85025 Blood Count | Office | 428 | 183 | $7.61 | $3,257 |
| 80053 Clinical Chemistry | Office | 423 | 181 | $10.35 | $4,378 |
| 99215 Office E&M - Established | Office | 170 | 88 | $106.61 | $18K |
| 99232 Hospital E&M - Subsequent | Facility | 112 | 47 | $57.51 | $6,441 |
| 99205 Office E&M - New | Office | 77 | 77 | $117.80 | $9,070 |
| 99233 Hospital E&M - Subsequent | Facility | 74 | 40 | $85.25 | $6,308 |
| 99223 Hospital E&M - Initial | Facility | 60 | 51 | $128.10 | $7,686 |
| 77080 Standard X-ray | Office | 41 | 41 | $24.83 | $1,018 |
| 99213 Office E&M - Established | Office | 12 | 12 | $33.22 | $399 |
By year: 2022 $611K for 45,538 services; 2023 $267K for 16,484 services; 2024 $133K for 3,704 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 510 | 244 | $8.63 | $4,403 |
| 85025 Blood Count | 428 | 183 | $7.61 | $3,257 |
| 80053 Clinical Chemistry | 423 | 181 | $10.35 | $4,378 |
Medicare prescription drug claims, 2024
In 2024, the drug Jessica N Snider prescribed most often to Medicare patients was Letrozole, with 403 prescriptions and refills. In total Jessica N Snider wrote 2,765 Medicare prescriptions that cost $9.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 403 | 930 | 109 | $5,147 |
| Anastrozole Generic | 134 | 290 | 35 | $1,335 |
| Cabometyx Cabozantinib S-Malate | 102 | 102 | Under 11 | $2.0M |
| Revlimid Lenalidomide | 91 | 91 | 13 | $1.8M |
| Gabapentin Generic | 74 | 101 | 22 | $948 |
| Pantoprazole Sodium Generic | 73 | 104 | 19 | $602 |
| Acyclovir Generic | 64 | 112 | 14 | $924 |
| Prednisone Generic | 63 | 65 | 29 | $207 |
| Jakafi Ruxolitinib Phosphate | 60 | 60 | Under 11 | $877K |
| Hydroxyurea Generic | 57 | 89 | 12 | $696 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 48 | 84 | 14 | $634 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 48 | 48 | 16 | $1,236 |
| Levothyroxine Sodium Generic | 47 | 89 | 11 | $172 |
| Eliquis Apixaban | 45 | 47 | Under 11 | $27K |
| Tamoxifen Citrate Generic | 45 | 117 | 17 | $1,011 |
Brand drugs: 706 claims; generic drugs: 2,059 claims; opioid claims: 131.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica N Snider $756 ($756 in general payments such as food, travel and fees) from 17 companies. The largest payer was Novartis Pharmaceuticals Corporation with $144.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 7 | $144 |
| Pfizer Inc. PFE | 9 | $138 |
| GlaxoSmithKline, LLC. GSK | 3 | $79.45 |
| Celgene Corporation BMY | 4 | $76.12 |
| Gilead Sciences, Inc. GILD | 2 | $47.68 |
| Exelixis Inc. EXEL | 1 | $32.87 |
| Astellas Pharma US Inc 4503.T | 1 | $31.65 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $30.82 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $27.21 |
| Incyte Corporation INCY | 1 | $23.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.